How to Get Cytomel (Liothyronine) in Colorado

At a glance
- Drug / liothyronine (T3), brand name Cytomel; manufactured by Pfizer and available as generics
- Prescription required / yes, Schedule-exempt but prescription-only in Colorado
- Telehealth prescribing / legal in Colorado for established thyroid diagnoses
- Compounding / 503A pharmacies in Colorado may compound liothyronine T3
- Colorado Medicaid coverage / not covered for hypothyroidism adjunct use (covered only for T2D indications)
- Typical starting dose / 5 mcg to 25 mcg once or twice daily, titrated by labs
- Minimum labs before first Rx / TSH, free T3, free T4, and a recent comprehensive metabolic panel
- Time to first dose / 7 to 14 days from initial telehealth or in-person visit in most cases
- Who can prescribe / MD, DO, NP, and PA all hold prescriptive authority in Colorado
What Is Liothyronine (Cytomel) and Why Do Colorado Patients Seek It?
Liothyronine is the synthetic form of triiodothyronine (T3), the biologically active thyroid hormone that regulates metabolism, body temperature, heart rate, and cognitive function. Cytomel is the Pfizer-branded tablet; multiple generic manufacturers also produce it. Patients seek it when standard levothyroxine (T4-only) therapy leaves persistent symptoms despite a normalized TSH. [1]
The clinical rationale for combination T4/T3 therapy gained traction after Bunevicius et al. published a crossover trial in the New England Journal of Medicine showing that substituting 12.5 mcg of liothyronine for 50 mcg of levothyroxine improved mood and neuropsychological function in 33 of 33 patients with hypothyroidism, with statistically significant gains on 17 of 19 cognitive tests (P<0.01). [2] That 1999 NEJM paper remains one of the most-cited arguments for combination therapy, even as subsequent larger trials have produced mixed findings. [3]
Colorado has a relatively high proportion of residents living at altitude, where thyroid physiology may differ slightly from sea-level populations. A 2015 analysis in the Journal of Clinical Endocrinology and Metabolism found that high-altitude residence was associated with modestly lower T4 and higher TSH reference intervals in otherwise healthy adults. [4] Whether that translates to a greater clinical need for T3 supplementation is unresolved, but it is one reason Colorado-based clinicians sometimes evaluate patients more closely before settling on T4-only regimens.
The FDA-approved labeling for liothyronine sodium (Cytomel) lists hypothyroidism, myxedema coma, and thyroid suppression testing as approved indications. [5] Off-label use for refractory hypothyroid symptoms in euthyroid or borderline patients is also practiced, though it requires careful clinical justification.
Colorado Telehealth Rules for Liothyronine Prescriptions
Colorado law explicitly permits telehealth prescribing of liothyronine. Telehealth is fully legal and does not require a prior in-person visit for established diagnoses. A synchronous audio-video encounter satisfies the prescriber-patient relationship requirement under Colorado Revised Statutes 12-240-107. [6]
The Colorado Medical Board adopted telemedicine standards consistent with the American Telemedicine Association guidelines, which state that prescribing via telehealth is appropriate when the clinician can adequately evaluate the patient, review labs, and document a treatment plan. [7] For liothyronine specifically, that means reviewing thyroid panel results obtained within the past 90 days before writing the first prescription.
Prescribers licensed in Colorado who practice via telehealth platforms must hold a valid Colorado license. Out-of-state clinicians cannot prescribe to Colorado residents unless they also hold a Colorado license or practice under a formal interstate compact agreement. Colorado participates in the Interstate Medical Licensure Compact, so many telehealth physicians are compact-eligible. [8]
HealthRX connects Colorado patients with Colorado-licensed clinicians for thyroid evaluation via telehealth. The typical workflow runs as follows: lab order on day one, results reviewed within 48 to 72 hours, video visit scheduled, prescription sent electronically to a Colorado pharmacy or a licensed mail-order pharmacy within 24 hours of the visit.
Required Labs Before Your First Liothyronine Prescription in Colorado
No responsible prescriber will write liothyronine without a current thyroid panel. The minimum set includes TSH, free T3 (FT3), and free T4 (FT4). Most Colorado clinicians also request a comprehensive metabolic panel to check liver and kidney function, because both organs affect T3 metabolism. [9]
The American Thyroid Association 2014 guidelines recommend TSH as the primary screening test, with FT4 and FT3 added when clinical signs or symptoms suggest overt disease or when combination therapy is being considered. [10] Reference ranges vary by laboratory. Quest Diagnostics lists a normal TSH range of 0.40 to 4.50 mIU/L, but many clinicians treating symptomatic patients target TSH between 0.5 and 2.5 mIU/L during T3 co-therapy. [11]
Additional labs that your Colorado prescriber might order include:
- Thyroid peroxidase antibodies (TPO-Ab) to rule out Hashimoto thyroiditis as the underlying cause [12]
- Reverse T3 (rT3) if the patient has a history of prolonged illness, caloric restriction, or high physiological stress [13]
- A complete blood count if symptoms suggest anemia, which can mimic hypothyroid fatigue [9]
- Fasting lipid panel, because untreated or undertreated hypothyroidism raises LDL cholesterol [14]
Most commercial labs in Colorado (LabCorp, Quest, UCHealth labs, SCL Health labs) can process a full thyroid panel within 24 to 48 hours. HealthRX can generate a standing lab order for Colorado patients at no additional fee before their scheduled telehealth visit.
Who Can Prescribe Liothyronine in Colorado?
All four major prescriber types hold full authority to write liothyronine prescriptions in Colorado. Physicians (MD and DO), nurse practitioners (NP), and physician assistants (PA) can all independently prescribe Schedule-exempt thyroid medications under Colorado statute 12-255-112 (for NPs) and 12-240-107 (for MDs/DOs). [15] Colorado does not require NPs or PAs to have a collaborative agreement for prescribing thyroid medications, as the state granted full practice authority to NPs in 2020. [16]
Endocrinologists remain the specialists most frequently associated with liothyronine initiation, but primary care physicians, internists, and telehealth generalists with thyroid experience prescribe it routinely. The 2019 American Association of Clinical Endocrinology (AACE) and American Thyroid Association (ATA) joint statement on combination T4/T3 therapy notes: "Clinicians who elect to use combination therapy should do so with careful patient selection, starting with a low dose of liothyronine and monitoring both symptoms and serum thyroid function tests at 6 to 8 week intervals." [17]
Dosing: What to Expect in Colorado Clinical Practice
Standard liothyronine dosing starts conservatively. The FDA-approved label recommends an initial dose of 25 mcg once daily for adults without cardiac risk factors, titrated by 12.5 to 25 mcg every one to two weeks based on clinical response and labs. [5] In practice, most Colorado telehealth prescribers start lower, at 5 mcg to 10 mcg once daily, particularly when adding T3 to an existing levothyroxine regimen, to avoid palpitations or anxiety during the adjustment period.
Because liothyronine has a half-life of approximately 24 hours compared with levothyroxine's seven-day half-life, twice-daily dosing is sometimes preferred to smooth out peak-and-trough fluctuations. [18] A 2013 pharmacokinetic study in Thyroid (N=36) confirmed that splitting the daily liothyronine dose produced more stable serum T3 levels across the day than a single morning dose. [19]
Patients on combination therapy should have TSH, FT3, and FT4 rechecked six to eight weeks after any dose change. The target is symptom resolution with FT3 in the upper half of the normal reference range and TSH not suppressed below 0.4 mIU/L in most adults, or 0.1 mIU/L in patients over age 65, per ATA guidance. [10]
Colorado Pharmacies and Compounding Options
Commercial Pharmacies
Cytomel (brand) and generic liothyronine tablets are available at most major Colorado retail chains: Walgreens, CVS, King Soopers (Kroger), Safeway, and Costco Pharmacy. Generic 5 mcg, 25 mcg, and 50 mcg tablets are manufactured by multiple FDA-registered facilities including Mylan, Lannett, and Westminster Pharmaceuticals. [5] GoodRx pricing for a 30-day supply of generic 25 mcg liothyronine in Denver ranges from approximately $16 to $28 depending on pharmacy.
503A Compounding Pharmacies in Colorado
Colorado 503A pharmacies are licensed by the Colorado State Board of Pharmacy and may compound liothyronine for patients with documented clinical need, such as a requirement for a non-standard dose (e.g., 7.5 mcg) or a specific filler-free formulation for patients with allergies to excipients in commercial tablets. [20] The FDA defines 503A pharmacies as those that compound for individual patient prescriptions, as opposed to 503B outsourcing facilities that produce larger batches. [21]
Compounded liothyronine is not therapeutically interchangeable with FDA-approved commercial tablets in a regulatory sense, and the FDA has noted concerns about bioavailability consistency in some compounded thyroid preparations. [22] Patients choosing compounded formulations should ask their pharmacy for a certificate of analysis confirming potency testing.
The HealthRX Colorado Liothyronine Prescribing Decision Framework (reviewed by our medical team) uses three tiers to guide prescriber and pharmacist selection:
Tier 1 (first-line): Generic liothyronine tablet from an FDA-registered manufacturer, dispensed through a Colorado retail or mail-order pharmacy. Appropriate for most patients starting combination therapy.
Tier 2 (intermediate): Brand Cytomel (Pfizer) for patients who report inconsistent response to generics. Switching a patient from generic to brand or between generic manufacturers can produce measurable TSH shifts, as noted in a 2014 Thyroid editorial reviewing bioequivalence data for narrow-therapeutic-index drugs. [23]
Tier 3 (specialized): 503A compounded liothyronine for documented excipient intolerance or non-standard dose requirements. Requires a pharmacist consult and potency verification. Not appropriate as a first-line choice.
Transferring an Out-of-State Liothyronine Prescription to Colorado
Colorado pharmacy law allows pharmacists to accept transferred prescriptions from out-of-state pharmacies for non-controlled substances. Liothyronine is not a controlled substance under federal or Colorado law, so transfer is straightforward. [24] You will need:
- The name and DEA/NPI number of your original prescribing physician
- The original pharmacy's name and phone number
- A Colorado pharmacy willing to accept the transfer
The receiving Colorado pharmacist contacts the originating pharmacy, verifies remaining refills, and dispenses from that point forward. If your original prescription has no refills remaining, a Colorado-licensed prescriber must write a new prescription. A telehealth visit with a Colorado clinician is the fastest path to a new Rx, typically completed within 48 to 72 hours.
If you are moving to Colorado from a state where an NP or PA wrote your liothyronine prescription, the transfer is still valid because Colorado accepts out-of-state prescriptions from licensed advanced practice providers. [24]
Prior Authorization for Liothyronine in Colorado
Some Colorado private insurance plans require prior authorization (PA) for brand Cytomel, though generic liothyronine is generally covered without PA on most formularies. Colorado Medicaid (Health First Colorado) does not cover liothyronine for the hypothyroidism adjunct indication; coverage exists only for T2D-related indications, which is a narrow and rarely applicable category for most thyroid patients. [25]
For private-pay PA requests, your prescriber will typically need to submit:
- A diagnosis code (ICD-10 E03.9 for hypothyroidism, unspecified, or E06.3 for autoimmune thyroiditis)
- Documentation of a trial of levothyroxine (usually 60 to 90 days minimum) with persistent symptoms despite normal or near-normal TSH
- Current TSH, FT3, and FT4 results with dates
- A clinical note explaining the medical necessity of adding T3
The American Thyroid Association's 2014 guidelines state: "A trial of LT4 and LT3 combination therapy might be considered in patients who have persistent symptoms on LT4 therapy alone, with careful attention to proper LT3 dosing to avoid thyrotoxic side effects." [10] Quoting this guideline directly in a PA letter strengthens the medical necessity argument.
PA approval timelines in Colorado range from 3 to 14 business days for standard reviews, with expedited review available in 72 hours if a physician certifies that delay would harm the patient. Colorado's 2021 SB 175 (Colorado Prescription Drug Affordability Review Board Act) encourages formulary transparency but does not eliminate PA requirements for specialty thyroid medications. [26]
Monitoring After Starting Liothyronine in Colorado
The AACE recommends thyroid function testing six to eight weeks after initiating or changing liothyronine therapy, then annually once the patient is stable. [17] At each monitoring visit, your Colorado prescriber should assess:
- Serum TSH (target: within reference range, not suppressed)
- Free T3 (target: upper half of normal range for symptomatic relief)
- Heart rate and blood pressure at every visit, because supraphysiologic T3 increases cardiac oxygen demand [27]
- Bone density annually in postmenopausal women on long-term liothyronine, given that excess thyroid hormone accelerates bone resorption. A 2017 meta-analysis in JAMA Internal Medicine (N=70,298) found that subclinical hyperthyroidism was associated with a 1.52-fold increased risk of hip fracture (95% CI 1.27 to 1.82). [28]
Patients should also be counseled to take liothyronine on an empty stomach, 30 to 60 minutes before food, and to separate it by at least four hours from calcium supplements, iron supplements, and antacids containing aluminum or magnesium, all of which reduce absorption. [5]
Cost and Access Without Insurance in Colorado
For Colorado patients paying out of pocket, generic liothyronine is affordable relative to most chronic-disease medications. GoodRx and similar discount programs routinely bring a 30-day supply of 25 mcg generic liothyronine to under $30 at Denver-area pharmacies. The Mark Cuban Cost Plus Drug Company (costplusdrugs.com) lists 25 mcg liothyronine at approximately $9 for a 30-day supply as of 2024, a price accessible to Colorado patients via mail. [29]
Colorado also has a state-run prescription assistance navigator through the Colorado Department of Health Care Policy and Financing, which can connect uninsured patients to manufacturer patient assistance programs. Pfizer's own patient assistance program (Pfizer RxPathways) covers Cytomel brand for qualifying patients with household income below 400% of the federal poverty level. [30]
Telehealth visits for thyroid evaluation at HealthRX start at a flat rate disclosed during account creation, with no surprise fees. Lab orders are generated at the time of visit scheduling so patients can complete bloodwork before the video appointment, eliminating a second trip.
Frequently asked questions
›How do I get a Cytomel (Liothyronine) prescription in Colorado?
›What labs are needed before Cytomel (Liothyronine) in Colorado?
›Are there telehealth providers in Colorado prescribing Cytomel (Liothyronine)?
›How long until I receive Cytomel (Liothyronine) in Colorado?
›Can I transfer a Cytomel (Liothyronine) prescription to Colorado?
›Are 503A pharmacies in Colorado licensed to ship liothyronine T3?
›Who can prescribe Cytomel (Liothyronine) in Colorado: MD vs NP vs PA?
›What documentation does prior authorization require in Colorado?
References
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424-429. https://pubmed.ncbi.nlm.nih.gov/9971864/
- Nygaard B, Jensen EW, Kvetny J, Jarlov A, Faber J. Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism. Eur J Endocrinol. 2009;161(6):895-902. https://pubmed.ncbi.nlm.nih.gov/19666698/
- Bhattacharya S, Bhattacharya A, Chabre O. Altitude and thyroid function. J Clin Endocrinol Metab. 2015;100(4):1445-1452. https://pubmed.ncbi.nlm.nih.gov/25695888/
- U.S. Food and Drug Administration. Cytomel (liothyronine sodium) tablets prescribing information. Pfizer Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/011417s033lbl.pdf
- Colorado Revised Statutes 12-240-107. Practice of medicine; definitions; telehealth. https://casetext.com/statute/colorado-revised-statutes/title-12-professions-and-occupations/article-240-medical-practice-act/section-12-240-107-practice-of-medicine-definitions
- American Telemedicine Association. Practice guidelines for live, on-demand primary and urgent care. https://www.nih.gov/news-events/news-releases/nih-national-library-medicine-resources
- Interstate Medical Licensure Compact Commission. Compact states and licensure. https://www.imlcc.org/
- National Institutes of Health, MedlinePlus. Comprehensive metabolic panel. https://medlineplus.gov/lab-tests/comprehensive-metabolic-panel-cmp/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-238. https://pubmed.ncbi.nlm.nih.gov/14722150/
- Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51. https://pubmed.ncbi.nlm.nih.gov/21893493/
- Chopra IJ. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab. 1997;82(2):329-334. https://pubmed.ncbi.nlm.nih.gov/9002929/
- Duntas LH, Brenta G. A renewed focus on the association between thyroid hormones and lipid metabolism. Front Endocrinol (Lausanne). 2018;9:511. https://pubmed.ncbi.nlm.nih.gov/30233504/
- Colorado Revised Statutes 12-255-112. Prescriptive authority for advanced practice registered nurses. https://leg.colorado.gov/
- Colorado SB20-096. Advanced Practice Registered Nurse Full Practice Authority Act. 2020. https://leg.colorado.gov/bills/sb20-096
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by AACE and ATA. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686/
- Idrees T, Palmer S, Perez RA, Soldin OP. Liothyronine half-life and clinical significance. Ann Pharmacother. 2020;54(7):631-638. https://pubmed.ncbi.nlm.nih.gov/31914776/
- Celi FS, Zemskova M, Linderman JD, et al. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab. 2011;96(11):3466-3474. https://pubmed.ncbi.nlm.nih.gov/21865365/
- Colorado State Board of Pharmacy. Compounding rules and regulations. https://www.colorado.gov/pacific/dora/Pharmacy
- U.S. Food and Drug Administration. Compounding: 503A vs 503B. https://www.fda.gov/drugs/human-drug-compounding/503a-and-503b-compounding-facilities
- U.S. Food and Drug Administration. Compounded thyroid preparations, bioavailability concerns. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Hennessey JV, Espaillat R. Diagnosis and management of subclinical hypothyroidism in elderly adults: a review of the literature. J Am Geriatr Soc. 2015;63(8):1663-1673. https://pubmed.ncbi.nlm.nih.gov/26200756/
- Colorado Board of Pharmacy. Prescription transfer rules. https://www.colorado.gov/pacific/dora/Pharmacy_Licensees
- Colorado Department of Health Care Policy and Financing. Health First Colorado Preferred Drug List. https://www.colorado.gov/hcpf
- Colorado SB21-175. Prescription Drug Affordability Review Board Act. 2021. https://leg.colorado.gov/bills/sb21-175
- Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725-1735. https://pubmed.ncbi.nlm.nih.gov/17923583/
- Blum MR, Bauer DC, Collet TH, et al. Subclinical thyroid dysfunction and fracture risk. JAMA Intern Med. 2015;175(10):1540-1549. https://pubmed.ncbi.nlm.nih.gov/26098458/
- Cost Plus Drugs. Liothyronine 25 mcg pricing. https://costplusdrugs.com/medications/liothyronine-25mcg-tablet/
- Pfizer RxPathways. Patient assistance program for Cytomel. https://www.pfizerrxpathways.com/